The Role of the Mitochondrial NCX in the Mechanism of Neurodegeneration in Parkinson's Disease

被引:25
|
作者
Wood-Kaczmar, Alison [1 ]
Deas, Emma [1 ]
Wood, Nicholas W. [1 ]
Abramov, Andrey Y. [1 ]
机构
[1] UCL Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England
基金
英国医学研究理事会; 英国惠康基金;
关键词
PINK1; Mitochondria; NCX; Calcium; Parkinson's disease; NA+/CA2+ EXCHANGERS; ESSENTIAL COMPONENT; CALCIUM; PINK1; NEURONS; BRAIN;
D O I
10.1007/978-1-4614-4756-6_20
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Mitochondrial Na+/Ca2+ exchange (NCXmito) is critical for neuronal Ca2+ homeostasis and prevention of cell death from excessive mitochondrial Ca2+ (m[Ca2+]) accumulation. The mitochondrial kinase PINK1 appears to regulate the mCa(2+) efflux from dopaminergic (DAergic) neurons, possibly by directly regulating NCXmito. However, the precise molecular identity of NCXmito is unknown and has been the subject of great controversy. Here we propose that the previously characterised plasmalemmal NCX isoforms (NCX2, NCX3) contribute to mitochondrial Na+/Ca2+ exchange in human DAergic neurons and may act downstream of PINK1 in the prevention of neurodegeneration by m[Ca2+] accumulation. Firstly, we definitively show the existence of a mitochondrial pool of endogenous plasmalemmal NCX isoforms in human DAergic neurons and cell lines using immunolocalisation and fluorescence-assisted organelle sorting (FAOS). Secondly, we demonstrate reduced mitochondrial Ca2+ efflux occurs following inhibition of NCX2 or NCX3 (but not NCX1) using siRNA or antibody blocking. This study has potentially revealed a new molecular target in Parkinson's disease pathology which ultimately may open up new avenues for future therapeutic intervention.
引用
收藏
页码:241 / 249
页数:9
相关论文
共 50 条
  • [1] Molecular mechanism of neurodegeneration in Parkinson's disease
    Chung, K. K.
    NEUROSIGNALS, 2006, 15 (01) : 42 - 42
  • [2] Extranigral Neurodegeneration in Parkinson's Disease A Role for Calpain in Neurodegeneration
    Samantaray, Supriti
    Butler, Jonathan T.
    Ray, Swapan K.
    Banik, Naren L.
    DRUG ADDICTION: RESEARCH FRONTIERS AND TREATMENT ADVANCES, 2008, 1139 : 331 - 336
  • [3] The Role of Ceruloplasmin in Neurodegeneration in Parkinson's Disease
    Gurer, Reyhan
    Aydin, Senay
    Gokce, Dilvin
    Ayaz, Tunahan
    Isik, Nihal
    TURKISH JOURNAL OF NEUROLOGY, 2016, 22 (01) : 19 - 25
  • [4] Brain mitochondrial dysfunction in aging, neurodegeneration, and Parkinson's disease
    Navarro, Ana
    Boveris, Alberto
    FRONTIERS IN AGING NEUROSCIENCE, 2010, 2
  • [5] Dopamine Oxidation Products as Mitochondrial Endotoxins, a Potential Molecular Mechanism for Preferential Neurodegeneration in Parkinson's Disease
    Biosa, Alice
    Arduini, Irene
    Soriano, Maria Eugenia
    Giorgio, Valentina
    Bernardi, Paolo
    Bisaglia, Marco
    Bubacco, Luigi
    ACS CHEMICAL NEUROSCIENCE, 2018, 9 (11): : 2849 - 2858
  • [6] Parkinson's disease and free radicals - Mechanism of neurodegeneration and neuroprotection
    Kondo, T
    PHARMACOLOGICAL INTERVENTION IN AGING AND AGE-ASSOCIATED DISORDERS: PROCEEDINGS OF THE SIXTH CONGRESS OF THE INTERNATIONAL ASSOCIATION OF BIOMEDICAL GERONTOLOGY, 1996, 786 : 206 - 216
  • [7] Invertebrate Models Untangle the Mechanism of Neurodegeneration in Parkinson's Disease
    Surguchov, Andrei
    CELLS, 2021, 10 (02) : 1 - 10
  • [8] Neuroinflammation in Parkinson's disease: role in neurodegeneration and tissue repair
    Vivekanantham, Sayinthen
    Shah, Savan
    Dewji, Rizwan
    Dewji, Abbas
    Khatri, Chetan
    Ologunde, Rele
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2015, 125 (10) : 717 - 725
  • [9] The role of iron in neurodegeneration - Prospects for pharmacotherapy of Parkinson's disease
    Jellinger, KA
    DRUGS & AGING, 1999, 14 (02) : 115 - 140
  • [10] Glial cells and inflammation in Parkinson's disease: A role in neurodegeneration?
    Hirsch, EC
    Hunot, S
    Damier, P
    Faucheux, B
    ANNALS OF NEUROLOGY, 1998, 44 (03) : S115 - S120